BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Onconova Therapeutics, Inc. to Provide Corporate Update and Second Quarter 2018 Financial ResultsCompany to Hold Conference Call and Webcast at 9:00 a.m. Eastern Time on Tuesday August 14, 2018

  Onconova Therapeutics, Inc. announced that the Company will release its second quarter 2018 financial results on August 14, 2018 before the market opens.

  August 7, 2018

   · 

  4 min read
• Business

  Progressive Care to Host Conference Call on Second Quarter 2018 Financial Results and Business Update on Aug. 14

  Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that the company will host a conference call on Tuesday, Aug. 14, 2018, at 4:30 PM ET to discuss financial results for the second quarter of 2018.

  August 7, 2018

   · 

  3 min read
• Health Canada Approves HEMLIBRA for Hemophilia A Patients with Inhibitors

  HEMLIBRA is the first new treatment in almost 20 years for this most severe form of hemophilia1 and the only medicine that is self-injected once weekly

  August 7, 2018

   · 

  11 min read
• Business

  Heska Reports Second Quarter Results

  Revenue $29.7 million

  August 7, 2018

   · 

  21 min read
• Drug Development

  Array BioPharma Receives FDA Breakthrough Therapy Designation for BRAFTOVI™ in combination with MEKTOVI® and cetuximab for BRAFV600E-mutant Metastatic Colorectal Cancer

  Array BioPharma, Inc. (NASDAQ: ARRY) today announced it has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for encorafenib.

  August 7, 2018

   · 

  14 min read
• Policy

  EVIO Labs Massachusetts Applies for Recreational Testing License

  EVIO Inc. announced that its Massachusetts lab has submitted its license application to the state’s Cannabis Control Commission and is seeking approval to be licensed as an independent testing laboratory under the Commission’s recently adopted adult use regulations.

  August 7, 2018

   · 

  2 min read
• Biotech Bay

  Eiger BioPharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference

  Eiger BioPharmaceuticals, Inc. announced that David Cory, President and CEO, will present a corporate update at the 2018 Wedbush PacGrow Healthcare Conference on August 15 at 2:30 PM ET.

  August 7, 2018

   · 

  1 min read
• Business

  TraceLink Joins Irish Medicines Verification Organization (IMVO) Serialization Pilot for Pharmacies and Clinics

  TraceLink Inc announced that it has joined the Irish Medicines Verification Organization (IMVO) serialization pilot study and will support a number of hospitals, pharmacies and clinics connect to the Irish Medicines Verification System (IMVS).

  August 7, 2018

   · 

  4 min read
• Policy

  Absorption Systems’ ACF Bioservices Certified by European Agency for GMP-compliant Alternative Therapeutic Medicinal Product Stability and Product Release Testing

  Absorption Systems® and its ACF Bioservices™ subsidiary announced that they have been certified by the European Medicines and Healthcare products Regulatory Agency (MHRA).

  August 7, 2018

   · 

  2 min read
• Drug Development

  Frequency Therapeutics Initiates Phase 1/2 Single Dose Clinical Trial to Evaluate FX-322, a First-in-Class Drug Candidate for Hearing Restoration

  Trial marks the first time a potential progenitor cell activator will be tested in adult patients with stable sensorineural hearing loss

  August 7, 2018

   · 

  5 min read